PPM1M and schizophrenia: It is plausible that PPM1M could be a key driver of the effect of these drugs: it is the top PhenomeXcan gene for bipolar disorder; a recent study found loci in this gene to be associated with schizophrenia (Goes et al. 2015); and another study linked the locus to rare mental illness (Mallard et al. 2022).